HomeHealth Care NewsStudy: Regular Use of Ivermectin Prevented COVID-19 Deaths

Study: Regular Use of Ivermectin Prevented COVID-19 Deaths

New evidence from a study of 223,123 people in Brazil shows ivermectin protected people from death by COVID-19.

“Non-use of ivermectin was associated with a 12.5-fold increase in mortality rate and a seven-fold increased risk of dying from COVID-19 compared to the regular use of ivermectin,” state the authors.

The study, “Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects,” was published on August 31 in Cureus.

One of the authors of the study is Pierre Kory, M.D., cofounder of the Front Line COVID-19 Critical Care Alliance. Kory testified before a U.S. Senate panel on December 8, 2020.

The August study builds on an earlier study published in January, which found ivermectin used as a prophylaxis for COVID-19 reduced infection, hospitalization, and mortality from the disease, even if not used as regularly as in the current study.

The new study zeroed in on subjects who regularly used the drug: 8,325 people in total. The subjects were part of a group of 223,128 residents of the Brazilian city of Itajai who were offered a chance to participate in a voluntary program to use ivermectin prophylactically between July and December of 2020. Among regular users, mortality rates were 92 percent lower in the group of regular users than for non-users and 84 percent lower than for those who used the drug irregularly.

In the United States, the National Institutes of Health (NIH) recommend against the use of ivermectin for COVID-19, except in clinical trials. The most recent update to the NIH’s webpage on the subject was on April 29. 2022.

After the January study, Joel Hirschhorn, author of the Pandemic Blunder Newsletter on Substack, wrote, “The P values (level of marginal significance) of this study are extraordinary and cannot be discounted easily by mainstream media. But clearly, the leftist mainstream media are not making these results major news stories. Use your critical thinking to make personal decisions to protect your health.”

—Staff reports

AnneMarie Schieber
AnneMarie Schieber
AnneMarie Schieber is a research fellow at The Heartland Institute and managing editor of Health Care News, Heartland's monthly newspaper for health care reform.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Most Popular

- Advertisement -spot_img
- Advertisement -spot_img

Recent Comments